Biglycan regulates bone development and regeneration
Frontiers in Physiology · 16.02.2023 · 14
DOI: 10.3389/fphys.2023.1119368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 16.02.2023. Verfasst von Reut Shainer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology of Bones and Teeth Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, Un…. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Endochondral bone development and regeneration relies on activation and proliferation of periosteum derived-cells (PDCs). Biglycan (Bgn), a small proteoglycan found in extracellular matrix, is known to be expressed in bone and cartilage, however little is known about its influence during bone development. Here we link biglycan with osteoblast maturation starting during embryonic development that later affects bone integrity and strength. Biglycan gene deletion reduced the inflammatory response after fracture, leading to impaired periosteal expansion and callus formation. Using a novel 3D scaffold with PDCs, we found that biglycan could be important for the cartilage phase preceding bone formation. The absence of biglycan led to accelerated bone development with high levels of osteopontin, which appeared to be detrimental to the structural integrity of the bone. Collectively, our study identifies biglycan as an influencing factor in PDCs activation during bone development and bone regeneration after fracture.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular Biology of Bones and Teeth Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, United States.
- NIDCR Imaging Core, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, United States.
- Department Genes-Circuits-Behavior, Max Planck Institute for Biological Intelligence, Martinsried, Germany.
- NIDCD/NIDCR Genomics and Computational Biology Core, National Institutes of Health, Bethesda, MD, United States.
- Biosystems and Biomaterials Division, National Institute of Standards and Technology, Gaithersburg, MD, United States.
- Pharmazentrum Frankfurt, Institut für Allgemeine Pharmakologie und Toxikologie, Klinikum der Goethe-Universität Frankfurt am Main, Frankfurt, Germany.
Förderung
- Intramural NIH HHS
Zitieren
APA
Shainer, R., Kram, V., Kilts, T. M., Li, L., Doyle, A. D., Shainer, I., Martin, D., Simon, C. G., Zeng-Brouwers, J., Schaefer, L., Young, M. F., & Genomics and Computational Biology Core (2023). Biglycan regulates bone development and regeneration. Frontiers in Physiology, 14. https://doi.org/10.3389/fphys.2023.1119368
Vancouver
Shainer R, Kram V, Kilts TM, Li L, Doyle AD, Shainer I, et al. Biglycan regulates bone development and regeneration. Frontiers in Physiology. 2023;14. doi:10.3389/fphys.2023.1119368
BibTeX
@article{Shainer2023,
author = {Shainer, Reut and Kram, Vardit and Kilts, Tina M and Li, Li and Doyle, Andrew D and Shainer, Inbal and Martin, Daniel and Simon, Carl G and Zeng-Brouwers, Jinyang and Schaefer, Liliana and Young, Marian F and Genomics and Computational Biology Core, Genomics and Computational Biology Core},
title = {Biglycan regulates bone development and regeneration},
journal = {Frontiers in Physiology},
year = {2023},
volume = {14},
doi = {10.3389/fphys.2023.1119368}
}
EUVIMED